Blog Posts: Medical Markets

TPP provides controversial new IP rights for biological drugs

Representatives of the United States and the eleven other parties to the Trans-Pacific Partnership agreed on groundbreaking protections for intellectual-property rights in biological drugs. But the standards are uneven, the result of eleventh-hour negotiations whose details remain largely secret.


Read More... (TPP provides controversial new IP rights for biological drugs)
No Comments | Posted by Sarah J. Sawyer on Wed. October 14, 2015 3:07 PM
Categories: Free Trade, Intellectual property, Medical Markets, United States, WikiLeaks, World Trade Organization

Dean Harris: Bioethics in Research

A UNC public-health professor's study of GMO rice from China raises bioethical questions.


Read More... (Dean Harris: Bioethics in Research)
No Comments | Posted by Charles E. Walsh on Mon. March 25, 2013 9:22 PM
Categories: China, Medical Markets, Symposium

Questions Without Answers: The Legal Frontier of Genomic Mapping

When Professor John Conley began his presentation on the ethical, moral, and legal implications of genomic mapping, he made one thing explicitly clear: there were not going to be a lot of answers in the following hour. Throughout the presentation he proved himself to be right by showing that frontier of genomic mapping just has not developed enough to answer many of the questions that it raises. However, the questions that Professor Conley did raise were quite thought-provoking. One in particular stood out: why can we not apply existing legal frameworks in the medical field to the emerging practice of diagnosis by genomic mapping?


Read More... (Questions Without Answers: The Legal Frontier of Genomic Mapping)
No Comments | Posted by David G. Russell on Mon. March 25, 2013 9:19 PM
Categories: Medical Markets, Symposium

Consumer Awareness as Part of the Solution to Imported Food Safety

Pharmaceutical outsourcing poses a range of regulatory and safety problems, according to one expert. 


Read More... (Consumer Awareness as Part of the Solution to Imported Food Safety)
No Comments | Posted by Susan Park on Mon. March 25, 2013 9:18 PM
Categories: Food and agriculture, Medical Markets, Symposium

Giving Bioethics Bite: A Look at What Underlies the Golden Rice Study Scandal

Professor Anne-Marie Duguet, M.D., Ph.D. (in law) visited the University of North Carolina School of Law from l’Université Paul Sabatier in Toulouse, France to address the recent controversy in China surrounding a study done on children and genetically modified rice. Specifically, Tang et al (“Tang”) performed a study on the nutritional value of Golden Rice – genetically modified rice that is rich in ß-carotene as a source of vitamin A, a vital nutrient for children – in the Hunan province of China. Seventy-two children from the ages of six to eight were subjected to the study. The children were then split into two randomized groups: a control group that ate natural foods high in ß-carotene and vitamin A and a test group of children who ate Golden Rice.


Read More... (Giving Bioethics Bite: A Look at What Underlies the Golden Rice Study Scandal)
No Comments | Posted by Seth T. Lawrence on Mon. March 25, 2013 9:15 PM
Categories: Medical Markets, Symposium

Professor Nathan Cortez: Legal Risks In Medical Tourism

Professor Cortez recently spoke at the “Medical Markets” Symposium held by the North Carolina Journal of International Law and Commercial Regulation of the legal ambiguities associated with the growing trend of medical tourism in an unregulated global health market. More patients are opting to leave the United States to have procedures done overseas for a variety of reasons—the procedure may be unavailable or illegal in the U.S., or perhaps cheaper elsewhere—yet they may not realize that they may be forgoing the legal protections of American courts. Patients are bearing the brunt of legal risks because it can be very difficult to successfully sue in the U.S. or overseas.


Read More... (Professor Nathan Cortez: Legal Risks In Medical Tourism)
No Comments | Posted by Danika J. Hoke on Mon. March 25, 2013 9:13 PM
Categories: Medical Markets, Symposium

Biobanking Without Borders: An International Perspective on the Ethics of Genomic Biobanking

In his keynote address, Professor Conley introduced plans for a bold study, conducted by the UNC School of Medicine, to identify several genes where mutations are strongly associated with common diseases, sequence those genes in a group of healthy human subjects, and then provide those subjects with information and counseling about their test results. Through his affiliation with the UNC Center for Genomics and Society, Professor Conley will study the ethical, legal and social implications (ELSI) of this kind of genomic biobanking as a public health tool.


Read More... (Biobanking Without Borders: An International Perspective on the Ethics of Genomic Biobanking)
No Comments | Posted by Amanda L. Gladin-Kramer on Mon. March 25, 2013 9:10 PM
Categories: Medical Markets, Symposium

Administrator Login

UNC School of Law | Van Hecke-Wettach Hall | 160 Ridge Road, CB #3380 | Chapel Hill, NC 27599-3380 | 919.962.5106


If you are seeing this, you are either using a non-graphical browser or Netscape 4.x (4.7, 4.8, etc.) and this page appears very plain. If you are using a 4.x version of Netscape, this site is fully functional but lacks styles and optimizations available in other browsers. For full functionality, please upgrade your browser to the latest version of Internet Explorer or Firefox.